Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Wolmark

Showing results (71-80 of 232) with videos related to

Pageof 24
Sort By:
Journal of Gastrointestinal Oncology|March 14, 2022
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatinGreg Yothers, Alan P Venook, Eiji Oki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296)Norman Wolmark, Walter J Curran, Frank Vicini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20Eleftherios P Mamounas, Gong Tang, Bernard Fisher, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2013
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I studyRachel C Jankowitz, Jame Abraham, Antoinette R Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative studyCarmen J Allegra, Soon Paik, Linda H Colangelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancerSherry X Yang, Joseph P Costantino, Chungyeul Kim, et al.
Future Oncology (London, England)|June 25, 2026
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual diseaseAnwaar Saeed, Greg Yothers, Shannon L Puhalla, et al.
The New England Journal of Medicine|January 21, 2011
Effect of occult metastases on survival in node-negative breast cancerDonald L Weaver, Takamaru Ashikaga, David N Krag, et al.
Journal of the National Cancer Institute|December 14, 2018
Current Activities of the Coalition of Cancer Cooperative GroupsMonica M Bertagnolli, Susan M Blaney, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27Eleftherios P Mamounas, Stewart J Anderson, James J Dignam, et al.
Pageof 24

Showing results (71-80 of 232) with videos related to

Sort By:
Pageof 24
Journal of Gastrointestinal Oncology|March 14, 2022
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatinGreg Yothers, Alan P Venook, Eiji Oki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296)Norman Wolmark, Walter J Curran, Frank Vicini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20Eleftherios P Mamounas, Gong Tang, Bernard Fisher, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2013
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I studyRachel C Jankowitz, Jame Abraham, Antoinette R Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative studyCarmen J Allegra, Soon Paik, Linda H Colangelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancerSherry X Yang, Joseph P Costantino, Chungyeul Kim, et al.
Future Oncology (London, England)|June 25, 2026
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual diseaseAnwaar Saeed, Greg Yothers, Shannon L Puhalla, et al.
The New England Journal of Medicine|January 21, 2011
Effect of occult metastases on survival in node-negative breast cancerDonald L Weaver, Takamaru Ashikaga, David N Krag, et al.
Journal of the National Cancer Institute|December 14, 2018
Current Activities of the Coalition of Cancer Cooperative GroupsMonica M Bertagnolli, Susan M Blaney, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27Eleftherios P Mamounas, Stewart J Anderson, James J Dignam, et al.
Pageof 24